You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 11 December 2024

Sec. Neuropharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1508703

Corrigendum: Edaravone dexborneol treatment attenuates neuronal apoptosis and improves neurological function by suppressing 4-HNE-associated oxidative stress after subarachnoid hemorrhage

  • The Second Affiliated Hospital, Brain Science Institute, School of Basic Medical Sciences of Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China

Article metrics

View details

1,1k

Views

428

Downloads

In the published article, there was an error in Supplementary Image 1. The inclusion of multiple brain images in the figure led to a typesetting oversight, resulting in the duplication of two brain images within the PBS and Eda Dexborneol groups. The correct Supplementary Image 1 is now published with the published article.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

oxidative stress, subarachnoid hemorrhage, edaravone dexborneol, 4-HNE, edaravone

Citation

Chen Q, Cai Y, Zhu X, Wang J, Gao F, Yang M, Mao L, Zhang Z and Sun B (2024) Corrigendum: Edaravone dexborneol treatment attenuates neuronal apoptosis and improves neurological function by suppressing 4-HNE-associated oxidative stress after subarachnoid hemorrhage. Front. Pharmacol. 15:1508703. doi: 10.3389/fphar.2024.1508703

Received

09 October 2024

Accepted

20 November 2024

Published

11 December 2024

Volume

15 - 2024

Edited and reviewed by

Rui Liu, Chinese Academy of Medical Sciences and Peking Union Medical College, China

Updates

Copyright

*Correspondence: Leilei Mao, ; Zongyong Zhang, ; Baoliang Sun,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics